| Latest Forum Topics / C&O Pharm |
 Post Reply
|
|
C&O Pharmaceutical
|
|||
|
tea444u
Master |
23-Dec-2010 14:23
|
||
|
x 0
x 0 Alert Admin |
i see like nothing ni happening here...got dividend some more boh? | ||
| Useful To Me Not Useful To Me | |||
|
Hulumas
Supreme |
21-Dec-2010 19:26
Yells: "INVEST but not TRADE please!" |
||
|
x 0
x 0 Alert Admin |
I 'll do accordingly!
|
||
| Useful To Me Not Useful To Me | |||
|
|
|||
|
masterlim
Senior |
21-Dec-2010 14:31
|
||
|
x 0
x 0 Alert Admin |
load up before you are left out ! | ||
| Useful To Me Not Useful To Me | |||
|
masterlim
Senior |
20-Dec-2010 22:25
|
||
|
x 0
x 0 Alert Admin |
c&o reverted to my email. see below for the responses. i hope i have helped fellow sharesholders to clarify to some extent. any questions, pop it to me and i will email to them again. hope tomorrow will cheong. load up before you are left out ! Hi Mr Lim, Thank you for your feedback. It is our policy not to comment on share price movement as it is a function of market forces that are beyond our control. C&O holds quarterly briefings for analysts and institutional investors. To reach out to the retail investors, we participate in seminars and lunchtime presentations organized by the broking houses. We also maintain an active IR website to keep investors posted about our latest corporate developments. Some of the major broking houses hold positive views about the C&O counter. We have attached some recent reports for your reference. The Company is always open to opportunities that will drive overall shareholder value. C&O’s strategies remain unchanged and the Group will continue to: - leverage on our R&D to launch new products and strengthen our portfolio of C&O Branded products; - expand our portfolio of Exclusive products by seeking collaboration opportunities to distribute new drugs in the PRC; - enhance our extensive distribution network; - leverage on R&D expertise to provide contract research services to foreign pharmaceutical companies Our management team remains in office although we have recently reconstituted the board with new members, namely, Mr. Tatsuya Suto (Non-executive Chairman), Mr Katsuya Okuyama (Executive Director), and Mr Michiharu Murakami (Non-executive Director). Mr Gao Bin, now our Deputy Chairman, will continue to spearhead C&O’s business. Sumitomo has a long track record in the drug licensing, which involves drugs mainly from Japan and Europe. We look forward to leverage on Sumitomo’s business to distribute new products in the PRC. Discussions between both parties are underway and we will share our plans in due course to update investors. China’s pharmaceutical market remains buoyant and is expected to see growth of more than 15% by 2020, and is also estimated to take over Japan as the world’s second largest market. We are not in the position to comment on Sumitomo’s strategies but we see a strategic fit between both C&O and Sumitomo for expanding our business in China. C&O can leverage on Sumitomo’s drug licensing business and their access to active pharmaceutical ingredients, while Sumitomo can tap on C&O’s R&D and manufacturing capabilities. Regards, August Consulting On behalf of C & O Pharmaceutical Technology (Holdings) Limited
|
||
| Useful To Me Not Useful To Me | |||
|
masterlim
Senior |
17-Dec-2010 07:25
|
||
|
x 0
x 0 Alert Admin |
load up before you are left out ! | ||
| Useful To Me Not Useful To Me | |||
|
|
|||
|
kc0257
Member |
17-Dec-2010 00:31
|
||
|
x 0
x 0 Alert Admin |
Thanks bro, That is an excellent writeup! Hope for prompt reply from them! |
||
| Useful To Me Not Useful To Me | |||
|
masterlim
Senior |
16-Dec-2010 23:48
|
||
|
x 0
x 0 Alert Admin |
i have managed to write to the IR in hk and spore side. i will update when they revert. do accumulate when it is less than 50 cents. hi all, The c&o share px is on the decline even with the annoucement of an injection of a strategic partner. i have been waiting for the news since sep/oct but it came finally only recently. The px did not even hold at 0.50 which sumitomo had offered to c&o to become one of the controlling sharesholders. i am utterly puzzled why the share px did not rise and hold on to the 0.50 level. The sharesholders are very depressed and fraustrated with the kind of stock performance it is showing to the investors. I believe it has huge plans ongoing but the public are uncertain about the new management. Can IR do something to address this concern to public? There are several catalysts which may boost the current share px. IR may consider the following to make its existence of the department worthwhile. (i) it seems like c&o is not listed in hk? considering a dual listing in hk can significantly jet up the buying interest of the public. (ii) provide updates on the new management strategic directions as public is confused as to what new plans are going underway. (iii) provide updates on any key discussions that c&o had with sumitomo on company key strategic plans to reassure public, good plans are undergoing. (iv) provide update on the strategic move into the china market which is on the sumitomo management's plate currently. The company has an excellent business model and its a shame that all the above issues are not addressed and communicated to the sharesholders, investors and the public at large in a timely and clear manner. You may want to provides some updates for the public to regain confidence after the new management had taken over. Thanks and appreciate your prompt action. |
||
| Useful To Me Not Useful To Me | |||
|
kc0257
Member |
14-Dec-2010 22:17
|
||
|
x 0
x 0 Alert Admin |
We hope to hear good news from you!!! Still disappointed with my much collection that it is still less than 50cents. C&O can u please CHEONG!!!! |
||
| Useful To Me Not Useful To Me | |||
|
|
|||
|
masterlim
Senior |
14-Dec-2010 18:51
|
||
|
x 0
x 0 Alert Admin |
let me write to the investor relations of the company and let you all know the status if there is any plan of dual listing. | ||
| Useful To Me Not Useful To Me | |||
|
w6m9hi
Senior |
14-Dec-2010 17:22
|
||
|
x 0
x 0 Alert Admin |
this counter should go duallisting in hk for higher value.. | ||
| Useful To Me Not Useful To Me | |||
|
masterlim
Senior |
14-Dec-2010 11:27
|
||
|
x 0
x 0 Alert Admin |
look out. it is starting to move up. will start to run up if its crosses 50 cents. accumulate now ! load up before you are left out ! |
||
| Useful To Me Not Useful To Me | |||
|
masterlim
Senior |
14-Dec-2010 01:07
|
||
|
x 0
x 0 Alert Admin |
starting to run up if its crosses 50 cents. accumulate now ! load up before you are left out ! |
||
| Useful To Me Not Useful To Me | |||
|
|
|||
|
masterlim
Senior |
13-Dec-2010 22:21
|
||
|
x 0
x 0 Alert Admin |
starting to run up if its crosses 50 cents. accumulate now ! load up before you are left out ! |
||
| Useful To Me Not Useful To Me | |||
|
kc0257
Member |
13-Dec-2010 21:29
|
||
|
x 0
x 0 Alert Admin |
Haha bro, u advertised 5 times already today!!!! Loaded.... best price today 0.485 Cheong!!!!!!!!!!!!!!!!!!!!!! hope 0.50 soon |
||
| Useful To Me Not Useful To Me | |||
|
masterlim
Senior |
13-Dec-2010 15:42
|
||
|
x 0
x 0 Alert Admin |
starting to run up if its crosses 50 cents. accumulate now ! load up before you are left out ! |
||
| Useful To Me Not Useful To Me | |||
|
masterlim
Senior |
13-Dec-2010 14:50
|
||
|
x 0
x 0 Alert Admin |
starting to run up if its crosses 50 cents. accumulate now ! load up before you are left out ! |
||
| Useful To Me Not Useful To Me | |||
|
masterlim
Senior |
13-Dec-2010 11:36
|
||
|
x 0
x 0 Alert Admin |
a very bargain px to accumulate. load up before you are left out. |
||
| Useful To Me Not Useful To Me | |||
|
masterlim
Senior |
13-Dec-2010 09:54
|
||
|
x 0
x 0 Alert Admin |
a very bargain px to accumulate. load up before you are left out. |
||
| Useful To Me Not Useful To Me | |||
|
masterlim
Senior |
12-Dec-2010 22:17
|
||
|
x 0
x 0 Alert Admin |
load up before you are left out. | ||
| Useful To Me Not Useful To Me | |||
|
masterlim
Senior |
10-Dec-2010 10:18
|
||
|
x 0
x 0 Alert Admin |
just some information on how extensive sumitomo network is. coupled with c&o network in china, and ageing population with the dependency on medicines for all ages group outline how important this industry is in. i believe it is a strategic investment in c&o and they are in the midst of outlining the corporate plans going forward. i see this as a good opportunity to accumulate. further annoucements will see this gem soar. Effective immediately, Sumitomo will be the exclusive sales agent for Chiral Quest in Japan and selected worldwide accounts. More than 40 percent of the ethical drugs manufactured today utilize chiral intermediate technology. Chiral chemocatalysts play a key role in the manufacture of medicines, fine chemicals, agricultural chemicals, and flavors and fragrances. "Chiral Quest is now in an expansion phase, and Sumitomo's international network of marketing and distribution facilities will enable us to provide our specialty chiral molecules quickly to pharmaceutical manufacturers globally at competitive prices," said Dr. Joseph Marasco, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Chiral Quest. "This is a venture that will be welcomed by the chiral molecule marketplace, and will allow us to efficiently serve our growing client base." Chiral Quest has wholly owned patents on a range of innovative chemical catalysts and processes used in the synthesis of chiral molecules. The company's primary laboratory and manufacturing facilities in New Jersey and China will now be supported by Sumitomo's extensive marketing capability and distribution network. Additional information on Chiral Quest is available at their website http://www.chiralquest.com/. "Sumitomo has been a major supplier to the global pharmaceutical industry for over the past four decades," noted Yasunori Ishibashi, senior director of the SCOA Medical Sciences Group. "This collaboration makes it possible for Sumitomo to play a significant role in the innovative and growing field of chiral technology." Sumitomo's established supply chain provides chemicals for a range of manufacturing processes. The company's chemical experts help specific clients in the field select and implement the most efficient synthesis process for producing specific molecules. The catalytic asymmetric hydrogenation process was discovered in 1987 by Dr. Ryoji Nyori. Over the past two decades, Nyori chiral technology has evolved rapidly and become widely applied in chemocatalysis. It has been especially valuable in the manufacture of chiral pharmaceutical products and fine chemicals. In 2001 Dr. Nyori shared the Nobel Prize in Chemistry The Nobel Prize in Chemistry (Swedish: Nobelpriset i kemi) is awarded once a year by the Royal Swedish Academy of Sciences. It is one of the six Nobel Prizes. The first prize was awarded in 1901. with William S. Knowles for their work in the study of chirally catalyzed hydrogenation. Sumitomo's global network includes 148 offices in 67 countries. Sumitomo also provides unique expertise in the import and export business. Through its global network for sales and distribution, Sumitomo has become a major resource for pharmaceutical companies. Sumitomo provides raw materials, production facilities, R&D facilities and various technical process support to major manufacturers in the pharmaceutical industry. |
||
| Useful To Me Not Useful To Me | |||